Back to Search
Start Over
TAV-in-TAV and Beyond: How Far Can We Go?
- Source :
-
JACC. Case reports [JACC Case Rep] 2023 Aug 11; Vol. 22, pp. 101974. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Competing Interests: Dr Taramasso has been a consultant or the recipient of consultancy fees from Abbott, Edwards Lifesciences, Boston Scientific, Shenqi Medical, CoreMedic, 4tech, Simulands, MTEx, Cardiovalve, and MEDIRA. Dr Tagliari has received a research grant from CAPES–Brazil (Finance Code 001); and has received a speaking fee from Biotronik. Dr Fischman has reported that he has no relationships relevant to the contents of this paper to disclose.
Details
- Language :
- English
- ISSN :
- 2666-0849
- Volume :
- 22
- Database :
- MEDLINE
- Journal :
- JACC. Case reports
- Publication Type :
- Editorial & Opinion
- Accession number :
- 37790778
- Full Text :
- https://doi.org/10.1016/j.jaccas.2023.101974